Dr. Doron Schneider and Dr. Jack Leahy discuss the Diabetes Control and Complications Trial and the follow up study, EDIC. These landmark, studies performed 30 years ago, have stood the test of time and still influences the standard of care today.

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM.  Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens.   By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.

Medicine

The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM. Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens. By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.

Share DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

Sign up to save your podcasts

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study